DalSolutions: Manufacturing the future of life‑saving medicine in Nova Scotia (opens in new tab)
Led by Dalhousie, BioLabs East will build a GMP — Good Manufacturing Practice — facility in Nova Scotia, producing vaccines and cell therapies for clinical trials while strengthening Canada’s biomanufacturing capacity and innovation ecosystem.
Read the original article